Anisodamine
- Generic Name
- Anisodamine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H23NO4
- CAS Number
- 55869-99-3
- Unique Ingredient Identifier
- 01343Q8EL8
- Background
Anisodamine has been investigated for the treatment of Intestinal Diseases.
- Indication
1.感染中毒性休克：如爆发性流行性脑脊髓膜炎、中毒性痢疾等（需要与抗生素合用）；
2.血管痉挛和栓塞引起的循环障碍：脑血栓形成、脑栓塞、瘫痪、脑血管痉挛、血管神经性头痛、血栓闭塞性脉管炎等；
3.平滑肌痉挛：胃溃疡、十二指肠溃疡、胆管、胰管、输尿管急性痉挛引起的绞痛或疼痛；
4.各种神经痛：如三叉神经痛、坐骨神经痛等；
5.眩晕病；
6.眼底疾病：中心性视网膜炎、视网膜色素变性、视网膜动脉血栓等；
7.突发性耳聋；
8.也用于有机磷中毒，但效果不如阿托品好；
9.其滴眼液可用于因睫状肌痉挛所造成的假性近视。
- Associated Conditions
- -
- Associated Therapies
- -
Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation
- Conditions
- Interventions
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Jie Chen
- Target Recruit Count
- 130
- Registration Number
- NCT06045364
- Locations
- 🇨🇳
The Second Affiliated Hospital Of Chongqing Medical University, Chongqing, Chongqing, China
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
- Conditions
- Interventions
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 194
- Registration Number
- NCT05727163
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Anisodamine Critically Ill SeptIc Shock
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Jinhua Central Hospital
- Target Recruit Count
- 355
- Registration Number
- NCT02442440
- Locations
- 🇨🇳
Huizhou first hospital, Huizhou, Guangdong, China
🇨🇳Union Hospital, Tongji medical collegue, Huazhong university of Science and Technology, Wuhan, Hubei, China
🇨🇳affiliated hospital, Jiangsu University, Zhenjiang, Jiangsu, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.